Navigation Links
BWH launches a new research division focused on integrating systems biology and medicine
Date:7/9/2012

BOSTON, MABrigham and Women's Hospital (BWH) announces the launch of the Channing Division of Network Medicine, a newly created research division within the Department of Medicine. The Channing Division of Network Medicine will use an integrated, network-based, systems biology-driven approach to define the causes of complex diseases. The research division plans to use this information to develop new ways to classify and treat those diseases.

This new division is led by Edwin K. Silverman, MD, PhD, chief of the Channing Division of Network Medicine. The Division includes the faculty and staff of the Chronic Disease Epidemiology Unit and the Respiratory, Genetic and Environmental Epidemiology Unit of the former Channing Laboratory, as well as a newly formed Systems Pathobiology Unit.

"By combining our clinical databases housing multiple research studies with genetic and epidemiological information on more than 300,000 people together with new systems biology capabilities, we will be able to combine multiple types of genetic and biochemical data using computational biology," said Silverman. "This will help us to understand the causes of disease and develop new biomarkers for diagnosis and therapeutic intervention. I look forward to working with my colleagues to foster a collaborative environment in which new discoveries about diseases are made that will benefit our patients."

Among the many ongoing research projects in the Division, the Nurses' Health Studythe largest, longest running study of women's healthhas provided important information documenting the health risks of smoking, obesity, trans fat and sugary beverages, as well as the benefits of physical activity, dietary fiber, healthy fats, fish and the complex relation of alcohol to health risks and benefits. The Systems Genetics and Genomics Unit has multiple ongoing research projects, which are primarily focused on respiratory disease. Recent highlights include the identification of genetic factors associated with therapeutic response to inhaled steroid medications in people with asthma and the identification of novel genetic risk factors for chronic obstructive pulmonary disease.

"The Channing Laboratory has been performing ground-breaking research since 1958, and there has been a strong tradition of attracting investigators of the highest caliber. In its new form, the Channing Division of Network Medicine is poised to continue this rich legacy and flourish under Dr. Silverman's leadership," said Joseph Loscalzo, MD, chairman of the Department of Medicine and director of the BWH Biomedical Research Institute.

The Channing Division of Network Medicine is comprised of Chronic Disease Epidemiology, Systems Genetics and Genomics, and Systems Pathobiology Units. It is home to world-renowned and long-running epidemiological studies. There are approximately 300 researchers and staff in this new Division of BWH. For more information, please visit channingnetworkmed.org.


'/>"/>

Contact: Marjorie Montemayor-Quellenberg
mmontemayor-quellenberg@partners.org
617-534-2208
Brigham and Women's Hospital
Source:Eurekalert

Related biology news :

1. LABS, Inc. Launches Suite of Next-Generation Test Offerings; Focuses on Expanding Complex Biologic Testing Portfolio in 2012
2. Elsevier launches new journal Algal Research
3. Clinical trial launches to see whether vitamin D helps treat multiple sclerosis
4. Thomson Reuters Launches Life Sciences Partner Ecosystem to Drive Collaborative R&D Drug Processes
5. WanderID Launches Breakthrough ID Product for Children, Seniors
6. Wiley-Blackwell launches new open-access journal: Food Science & Nutrition
7. MindSpec launches online Autism Reading Room
8. NineSigma Launches NineSights, the Worlds First Open Innovation Social Media Destination for Innovation Seekers and Solution Providers
9. PuraMed BioScience®, Inc., Launches a Marketing Blitz for LipiGesic® M, Its Clinically-Tested Migraine Pain Reliever in the Denver, CO Region to Coincide with the NACDSs Marketplace 2012 Trade Convention
10. NIST launches new website to educate industry about alternatives to mercury thermometers
11. Spectros Launches OnCall Wireless Remote Access for T-Stat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/1/2016)... Canada , February 1, 2016 ... technological advancements to drive global touchfree intuitive gesture control ... --> Rising sales of consumer electronics coupled ... gesture control market size through ... consumer electronics coupled with new technological advancements to drive ...
(Date:1/25/2016)... BELL, Pa. , Jan. 25, 2016   Unisys Corporation ... recognition system at John F. Kennedy (JFK) International Airport, ... Border Protection (CBP) identify imposters attempting to enter ... do not belong to them. pilot testing of ... out initially at three terminals at JFK during January 2016. ...
(Date:1/20/2016)... 20, 2016 A market that just keeps ... from the explosion in genomics knowledge. Learn all about ... A range of dynamic trends are pushing market growth ... medicine - pharmacogenomics - pathogen evolution - next generation ... - greater understanding of the role of genetic material ...
Breaking Biology News(10 mins):
(Date:2/8/2016)... Novan, Inc. today announced that Director Robert A. Ingram ... In addition, Robert Keegan has been appointed to the ... --> North Carolina . ... of $32.8 million of net proceeds in a private Mezzanine B ... the Research Triangle area of North Carolina . ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... of Semantic Graph Database technology, today announced the availability of AllegroGraph 6, the ... through the Cloudera Certified Technology Program (CCPT). AllegroGraph is the first ...
(Date:2/6/2016)... ... ... The Center for Excellence in Education (CEE) will sponsor a Bite of Science ... 2016. This Bite of Science session, hosted by the Smithsonian-Mason School of Conservation, ... in Front Royal, VA from 5:00 p.m. to 8:00 p.m. The dinner is for ...
(Date:2/5/2016)... February 5, 2016 Amarantus BioScience ... company focused on developing products for Regenerative Medicine, Neurology ... Pediatric Disease Designation (RPDD) from the US Food and ... MANF. MANF was previously granted orphan drug designation (ODD) ... Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), ...
Breaking Biology Technology: